University of Ioannina
Microdosimetric calculations for the determination of safe radiation dose limits for manned long-term space missions
Abstract
dc:descriptionBackground: Space radiation poses the foremost health risk for astronauts, with the potential for carcinogenesis from Galactic Cosmic Rays (GCR) being the main constraint for long-duration missions beyond low Earth orbit (BLEO). Estimating the cancer risk is challenging due to limited astronaut epidemiological data. The reference radiation studies stem from the atomic bomb survivors (LSS), which aren't ideal reference population, as they involved high dose rates and low-LET radiation, while astronauts face mainly low dose rates and a broader LET spectrum in space. Until recently, all missions have been in Low-Earth Orbit (LEO), so the differences in cancer risk assessment among space agencies did not pose issues for mission planning. However, for Beyond-LEO (BLEO) missions, where doses are higher and encounters with heavy ions are more frequent, uncertainties in estimating the cancer risk are notable. The greatest uncertainty in risk estimation is in calculating the quality factor (Q) of space radiation. Currently, there is no consensus among space agencies regarding the theoretical calculation of Q, while experimental data for the heavy ions from GCR is limited. NASA diverged from the LET-based method (recommended by ICRP Report 60), which was previously used to calculate Q in LEO missions. Instead, NASA estimates Q as a function of the track-structure parameter (Z/β)2. Meanwhile, other space agencies, such as ESA, JAXA and RSA continue to use the LET-based method. However, the LET approach has significant limitations in predicting the quality of space radiation. It simplifies the interaction of radiation with living matter and presents inaccuracies for the diverge space radiation. In addition, it is not a directly measurable quantity, as well as it predicts that ions with the same LET have the same biological effectiveness, which is incorrect due to variations in their different track structure. Purpose: The study aims to apply the microdosimetric Q from the well-established Theory of Dual Radiation Action (TDRA) for space radiation and manned space missions, as well as established cancer risk metrics and safe days for astronauts. We developed a semi-analytic method for calculating the required microdosimetric quantity lineal energy (y), which is a better descriptor of radiation quality than LET and it is also measurable by TEPC (tissue-equivalent proportional counter) detectors, as used in space shuttle missions and the ISS. Methodology: During the doctoral project, we have modified the US Naval Research Laboratory (NRL) microdosimetric model (developed by Xapsos and co-workers) for application to the space radiation environment, by extending its application to heavy ions (up to iron) and up to few GeV/u, extending its reliability to nanometer target sizes and combining direct (ion) and indirect (δ-ray) events using Geant4-DNA simulations and models. Our new microdosimetric model was benchmarked against proton Monte Carlo track-structure simulation data from PHITS, RITRACKs and Geant4-DNA for target-spheres from 10-1000 nm. Results: Our microdosimetric calculations were in very good agreement (within 10%) with the MCTS data for all spheres. The extended-NRL model was used to calculate TDRA-based average quality factors (Q) for the GCR spectrum in two simple mission scenarios, i.e., at ISS and at 1 AU in deep space. Our quality factor predictions were in excellent agreement (within 1-3%) with the latest NASA model. Our quality factor predictions were in excellent agreement (within experimental uncertainties) with TEPC measurements at ISS and at the MSL RAD (deep space). Additionally, the values of the quality factor (Q) were used to calculate radiation-induced cancer risk for space mission scenarios to the Moon and Mars. The cancer risk assessments indicated that, for a mission to Mars, women under the age of 35–40 are the most radiosensitive group and therefore exceed or are at risk of exceeding the maximum radiation dose limits set by the space agencies of ESA and NASA, respectively. In contrast, missions to the Moon remain within dose limits, provided they last less than approximately 2 years. Conclusions: The proposed semi-analytic microdosimetric model with TDRA quality factor estimations, is expected to be both practical and reliable for the assessment of cancer risk for astronauts in deep space missions, where no space agency has yet established specific radiation risk limits.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadopoulos, Alexios
- Παπαδόπουλος, Αλέξιος
Subjects
dc:subject × 17- Μικροδοσιμετρια
- Ακτινοπροστασία
- Καρκινογένεση
- Διαστημικές αποστολές
- Ιατρική φυσική
- Παράγοντας ποιότητας Q
- Microdosimetry
- Radiation protection
- Carcinogenesis
- Quality factor Q
- Space
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική, άλλοι τομείς
- Other Medical Sciences
- Medical and Health Sciences
- Medicine, miscellaneous
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59007